Purdue Pharma to stop marketing opioids to U.S. physicians, but policy not extended to Canada Whitecourt Press February 11, 2018 1 min read Numerous lawsuits and top health officials in both Canada and the U.S. link Purdue’s OxyContin drug to the fentanyl-driven overdose crisis
